The monoamine neurotransmitter transporters: Structure, conformational changes and molecular gating

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 5, 2001, Pages 591-601

  Norregaard, L ^a   Gether, U ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cocaine; Conformational changes; Gating mechanisms; Monoamine transporter; Na+ Cl dependent transporter; Structure

Indexed keywords

1 [1 (2 BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE; 1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; AMPHETAMINE; ANTIDEPRESSANT AGENT; CARRIER PROTEIN; CITALOPRAM; COCAINE; DOPAMINE; FLUOXETINE; IMIPRAMINE; MAZINDOL; METHYLPHENIDATE; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; PSYCHOTROPIC AGENT; SEROTONIN; SODIUM CHLORIDE; LIGAND;

CELL MEMBRANE; CHANNEL GATING; CONFORMATIONAL TRANSITION; DRUG ABUSE; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RESEARCH; REVIEW; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; HUMAN; METABOLISM;

ANIMAL; CARRIER PROTEINS; HUMAN; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NEUROTRANSMITTERS;

EID: 0034807252     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. The sequence of the human genome
2. Neurotransmitter transporters: Recent progress
3. Molecular characterization of the dopamine transporter
4. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
5. Molecular physiology and regulation of catecholamine transporters
6. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference
7. Three-dimensional structure of the ion-coupled transport protein NhaA
8. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: Relevance to cocaine sensitivity (1)
9. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands
10. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
11. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenyl-pyridinium
12. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants
13. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
14. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter
15. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol
16. Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter
17. Tyrosine-533 of rat dopamine transporter: Involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine
18. Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition
19. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression
20. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains
21. Dopamine transporter transmembrane domain polar mutants: δG and δδG values implicate regions important for transporter functions
22. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis
23. Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition
24. Critical amino acid residues in transmembrane span 7 of the serotonin transporter identified by random mutagenesis
25. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding
26. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and extracellular loops of the human dopamine transporter
27. Permeation and gating residues in serotonin transporter
28. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter
29. 2+-binding site
30. 2+ binding sites
31. Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains
32. Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine-analogue as a molecular reporter
33. - neurotransmitter transporters
34. Dopamine transporter cysteine mutants: Second extracellular loop cysteines are required for transporter expression
35. External cysteine residues in the serotonin transporter
36. The rat serotonin transporter: Identification of cysteine residues important for substrate transport
37. An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism
38. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody
39. Antipeptide antibodies confirm the topology of the human norepinephrine transporter
40. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
41. Determination of external loop topology in the serotonin transporter by site-directed chemical labeling
42. Delineation of an endogenous zinc-binding site in the human dopamine transporter
43. 2+ switches in the GABA transporter-1: Differential effects on GABA uptake and currents
44. Projection structure of NhaA, a secondary transporter from Escherichia coli, at 4.0 Å resolution
45. Cloning and functional characterization of a cocaine-sensitive dopamine transporter
46. Cloning and expression of a cocaine-sensitive rat dopamine transporter
47. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
48. Cloning of the cocaine-sensitive bovine dopamine transporter
49. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter
50. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter
51. Cloning and expression of a functional serotonin transporter from rat brain
52. Dopamine uptake by serotonin transporters: Mechanistic and physiological implications
53. The structure and function of norepinephrine, dopamine, and serotonin transporters
54. Structure and function of the dopamine transporter
55. MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture
56. Parkinson's disease and the electron transport chain
57. Transporter explosion: Update on uptake
58. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters
59. Dopamine uptake blockers: Structure-activity relationships
60. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity
61. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor
62. Allele-specific activation of genetically engineered receptors
63. Tyrosine 140 of the γ-aminobutyric acid transporter GAT-1 plays a critical role in neurotransmitter recognition
64. Transmembrane domain III plays an important role in ion binding and permeation in the glycine transporter GLYT2
65. Heteromultimeric channels formed by rat brain potassium-channel proteins
66. Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes
67. Protein tyrosine kinase receptors
68. + conduction and selectivity
69. Three-dimensional structure of a voltage-gated potassium channel at 2.5 nm resolution
70. Oligomerization of G-protein-coupled transmitter receptors
71. Oligomerization of dopamine and serotonin receptors
72. Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy
73. Properties of permease dimer, a fusion protein containing two lactose permease molecules from Escherichia coli
74. Pentameric assembly of a neuronal glutamate transporter
75. Molecular organization of the human serotonin transporter at the air/water interface
76. Possible existence of quaternary structure in the high-affinity serotonin transport complex
77. Oligomerization of serotonin transporter and its functional consequences
78. Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells
79. 306 at the extracellular end of TM6
80. Surface-localized glycine transporters 1 and 2 function as monomeric proteins in Xenopus oocytes
81. Simple allosteric model for membrane pumps
82. The reactivity of the γ-aminobutyric acid transporter GAT-1 toward sulfhydryl reagents is conformationally sensitive. Identification of a major target residue
83. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter
84. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A
85. Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
86. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain - Containing protein PICK1